First Tracks Biotherapeutics, Inc. Ordinary Shares TRAX Business Segments
No data available yet.
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does First Tracks Biotherapeutics, Inc. Ordinary Shares break its business down?
- First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) reports research and development expense reversal excluding acquired in process cost by business across 5 parts — ANB032, ANB033, ANB101, Preclinical And Other Unallocated Costs and Rosnilimab. Each is extracted from the segment footnotes and tracked over time.
- Where does First Tracks Biotherapeutics, Inc. Ordinary Shares's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in First Tracks Biotherapeutics, Inc. Ordinary Shares's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.